---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-23-000045"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T19:53:16.180955+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical Q2 revenue up 32% to $13.6M, net loss narrows 82% to $1.0M, reaffirms FY2023 guide

## Summary
- Advanced Energy revenue rose 40% YoY to $11.7M; OEM revenue fell 4% to $1.8M.
- Net loss improved to $1.0M ($0.03 loss per share) from $5.4M in Q2 2022.
- Adjusted EBITDA loss decreased 52% to $1.6M; gross margin expanded to 68.4%.
- FY2023 outlook reaffirmed: total revenue $59-62M, Advanced Energy $51-54M, net loss ~$10.5M.
- Completed sale-leaseback of Clearwater facility, netting ~$6.6M; received two FDA 510(k) clearances in Q2.

## SEC filing metadata
- accession: 0000719135-23-000045
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913523000045/0000719135-23-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913523000045/apyx-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-23-000045
- JSON: https://secwatch.observer/filing/0000719135-23-000045.json
- Plain text: https://secwatch.observer/filing/0000719135-23-000045.txt

## Key facts
- Earnings Releases
  Apyx Medical Corp reported second quarter ended June 30, 2023 results: revenue $13.6 million, net income Net loss attributable to stockholders of $1.0 million. Guidance reaffirmed.
  - Period: second quarter ended June 30, 2023
  - Revenue: $13.6 million
  - Net income: Net loss attributable to stockholders of $1.0 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: second quarter ended June 30, 2023, and reaffirms financial expectations for the full year ending December 31, 2023. Second Quarter 2023 Financial Summary : • Total revenue of $13.6 million, up 32% year-over-year. ◦ Advanced Energy revenue of $11.7 million, up 40% year-over-year. ◦ OEM revenue of $1.8 million, down 4% year-over-year. • Net loss attributable to
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913523000045/0000719135-23-000045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.